date：2019-01-02 Views：9328 times
查看研報(bào)附件：信達(dá)國際-康臣藥業(yè)1681：2018年上半年收入實(shí)現(xiàn)穩(wěn)定增長，推薦買入評(píng)級(jí)，目標(biāo)價(jià)9.6港元。
Prev：China / Hong Kong Company Guide Consun Pharmaceutical Group
Next：None
400-930-1681
service@chinaconsun.com
71 Dongpeng Avenue, Huangpu District, Guangzhou
Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration
粵ICP備15001491號(hào)Design: uweb
